Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hartmann

Showing results (541-550 of 941) with videos related to

Pageof 95
Sort By:
Journal of the American Chemical Society|July 19, 2017
Giant PbSe/CdSe/CdSe Quantum Dots: Crystal-Structure-Defined Ultrastable Near-Infrared Photoluminescence from Single NanocrystalsChristina J Hanson, Nicolai F Hartmann, Ajay Singh, et al.
Der Orthopade|January 23, 2019
T R Blattert, K J Schnake, O Gonschorek, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1971
[Exchange transfusions in acute liver failure]G Baltzer, W Dölle, U Bär, et al.
Genes|May 28, 2022
Long-Term Follow-Up of Three Family Members with a Novel <i>NNT</i> Pathogenic Variant Causing Primary Adrenal InsufficiencyTjasa Krasovec, Jaka Sikonja, Mojca Zerjav Tansek, et al.
European Journal of Endocrinology|November 8, 2012
Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profilingG G Lavery, J Idkowiak, M Sherlock, et al.
Alimentary Pharmacology & Therapeutics|October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyA Stallmach, C Langbein, R Atreya, et al.
Hormone Research in Paediatrics|July 2, 2026
Circulating mRNA and miRNA signatures used as predictive markers of lifestyle modification outcomes in pediatric obesity managementAneta M Gawlik-Starzyk, Michael Shmoish, Abdullah Bereket, et al.
Leukemia|April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemiaR F Schlenk, U Germing, F Hartmann, et al.
Pageof 95

Showing results (541-550 of 941) with videos related to

Sort By:
Pageof 95
Journal of the American Chemical Society|July 19, 2017
Giant PbSe/CdSe/CdSe Quantum Dots: Crystal-Structure-Defined Ultrastable Near-Infrared Photoluminescence from Single NanocrystalsChristina J Hanson, Nicolai F Hartmann, Ajay Singh, et al.
Der Orthopade|January 23, 2019
T R Blattert, K J Schnake, O Gonschorek, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1971
[Exchange transfusions in acute liver failure]G Baltzer, W Dölle, U Bär, et al.
Genes|May 28, 2022
Long-Term Follow-Up of Three Family Members with a Novel <i>NNT</i> Pathogenic Variant Causing Primary Adrenal InsufficiencyTjasa Krasovec, Jaka Sikonja, Mojca Zerjav Tansek, et al.
European Journal of Endocrinology|November 8, 2012
Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profilingG G Lavery, J Idkowiak, M Sherlock, et al.
Alimentary Pharmacology & Therapeutics|October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyA Stallmach, C Langbein, R Atreya, et al.
Hormone Research in Paediatrics|July 2, 2026
Circulating mRNA and miRNA signatures used as predictive markers of lifestyle modification outcomes in pediatric obesity managementAneta M Gawlik-Starzyk, Michael Shmoish, Abdullah Bereket, et al.
Leukemia|April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemiaR F Schlenk, U Germing, F Hartmann, et al.
Pageof 95